The Future of HIV-1 Therapeutics - Resistance Is Futile? (Paperback, Softcover reprint of the original 1st ed. 2015)

This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike.

General

Imprint:	Springer International Publishing AG
Country of origin:	Switzerland
Series:	Current Topics in Microbiology and Immunology, 389
Release date:	October 2016
First published:	2015
Editors:	Bruce E. Torbett • David S Goodsell • Douglas D. Richman
Dimensions:	235 x 155 x 14mm (L x W x T)
Format:	Paperback
Pages:	254
Edition:	Softcover reprint of the original 1st ed. 2015
ISBN-13:	978-3-319-37450-5
Categories:	Books > Medicine > Other branches of medicine > Pathology > Medical microbiology & virology Books > Medicine > Other branches of medicine > Pharmacology > General Books > Medicine > Clinical & internal medicine > Diseases & disorders > Infectious & contagious diseases > General
LSN:	3-319-37450-8
Barcode:	9783319374505

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!